Classical/nonclassical hybrid cannabinoids

Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues

David J. Drake, Rader S. Jensen, Jakob Busch-Petersen, Joel K. Kawakami, M. Concepcion Fernandez-Garcia, Pusheng Fan, Alexandros Makriyannis, Marcus A. Tius

    Research output: Contribution to journalArticle

    43 Citations (Scopus)

    Abstract

    The stereoelectronic requirements for interaction of the southern aliphatic hydroxyl of cannabimimetic pharmacophores with the CB1 and CB2 receptors are explored. The stereoselective syntheses of three series of classical/nonclassical hybrid cannabinoids are described. These compounds were designed to investigate the importance of the southern aliphatic hydroxyl (SAH) pharmacophore for cannabimimetic activity. Variation in the chain length of the SAH moiety in these 6β-(hydroxyalkyl)dihydrobenzopyran analogues, from 6β-hydroxymethyl to 6β(ω-hydroxyethyl) and 6β-(ω- hydroxypropyl), and the effects of replacing the hydroxyl functional, ity by hydride and iodide are reported. Our results indicate that the SAH pharmacophore has less pronounced effects than the C-3 aliphatic chain on cannabinoid activity. Furthermore, it appears that this southern molecular component is capable of interacting with two different subsites on the receptor and that the nature of this interaction is determined by the terminal substituent on the C-6β alkyl group. One of the subsites can accommodate the relatively polar SAH pharmacophore, while the second subsite interacts with more hydrophobic C-6β substituents and can accommodate large spherical pharmacophores separated by three methylene carbons from the tricyclic cannabinoid template.

    Original languageEnglish
    Pages (from-to)3596-3608
    Number of pages13
    JournalJournal of Medicinal Chemistry
    Volume41
    Issue number19
    DOIs
    Publication statusPublished - 1998 Sep 10

    Fingerprint

    Cannabinoids
    Hydroxyl Radical
    Chromans
    Cannabinoid Receptor CB2
    Cannabinoid Receptor CB1
    Iodides
    Chain length
    Hydrides
    Carbon

    ASJC Scopus subject areas

    • Organic Chemistry

    Cite this

    Drake, D. J., Jensen, R. S., Busch-Petersen, J., Kawakami, J. K., Fernandez-Garcia, M. C., Fan, P., ... Tius, M. A. (1998). Classical/nonclassical hybrid cannabinoids: Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues. Journal of Medicinal Chemistry, 41(19), 3596-3608. https://doi.org/10.1021/jm960677q

    Classical/nonclassical hybrid cannabinoids : Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues. / Drake, David J.; Jensen, Rader S.; Busch-Petersen, Jakob; Kawakami, Joel K.; Fernandez-Garcia, M. Concepcion; Fan, Pusheng; Makriyannis, Alexandros; Tius, Marcus A.

    In: Journal of Medicinal Chemistry, Vol. 41, No. 19, 10.09.1998, p. 3596-3608.

    Research output: Contribution to journalArticle

    Drake, DJ, Jensen, RS, Busch-Petersen, J, Kawakami, JK, Fernandez-Garcia, MC, Fan, P, Makriyannis, A & Tius, MA 1998, 'Classical/nonclassical hybrid cannabinoids: Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues', Journal of Medicinal Chemistry, vol. 41, no. 19, pp. 3596-3608. https://doi.org/10.1021/jm960677q
    Drake, David J. ; Jensen, Rader S. ; Busch-Petersen, Jakob ; Kawakami, Joel K. ; Fernandez-Garcia, M. Concepcion ; Fan, Pusheng ; Makriyannis, Alexandros ; Tius, Marcus A. / Classical/nonclassical hybrid cannabinoids : Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues. In: Journal of Medicinal Chemistry. 1998 ; Vol. 41, No. 19. pp. 3596-3608.
    @article{4535f1caa03245daa2d22b20373537c5,
    title = "Classical/nonclassical hybrid cannabinoids: Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues",
    abstract = "The stereoelectronic requirements for interaction of the southern aliphatic hydroxyl of cannabimimetic pharmacophores with the CB1 and CB2 receptors are explored. The stereoselective syntheses of three series of classical/nonclassical hybrid cannabinoids are described. These compounds were designed to investigate the importance of the southern aliphatic hydroxyl (SAH) pharmacophore for cannabimimetic activity. Variation in the chain length of the SAH moiety in these 6β-(hydroxyalkyl)dihydrobenzopyran analogues, from 6β-hydroxymethyl to 6β(ω-hydroxyethyl) and 6β-(ω- hydroxypropyl), and the effects of replacing the hydroxyl functional, ity by hydride and iodide are reported. Our results indicate that the SAH pharmacophore has less pronounced effects than the C-3 aliphatic chain on cannabinoid activity. Furthermore, it appears that this southern molecular component is capable of interacting with two different subsites on the receptor and that the nature of this interaction is determined by the terminal substituent on the C-6β alkyl group. One of the subsites can accommodate the relatively polar SAH pharmacophore, while the second subsite interacts with more hydrophobic C-6β substituents and can accommodate large spherical pharmacophores separated by three methylene carbons from the tricyclic cannabinoid template.",
    author = "Drake, {David J.} and Jensen, {Rader S.} and Jakob Busch-Petersen and Kawakami, {Joel K.} and Fernandez-Garcia, {M. Concepcion} and Pusheng Fan and Alexandros Makriyannis and Tius, {Marcus A.}",
    year = "1998",
    month = "9",
    day = "10",
    doi = "10.1021/jm960677q",
    language = "English",
    volume = "41",
    pages = "3596--3608",
    journal = "Journal of Medicinal Chemistry",
    issn = "0022-2623",
    publisher = "American Chemical Society",
    number = "19",

    }

    TY - JOUR

    T1 - Classical/nonclassical hybrid cannabinoids

    T2 - Southern aliphatic chain- functionalized c-6β methyl, ethyl, and propyl analogues

    AU - Drake, David J.

    AU - Jensen, Rader S.

    AU - Busch-Petersen, Jakob

    AU - Kawakami, Joel K.

    AU - Fernandez-Garcia, M. Concepcion

    AU - Fan, Pusheng

    AU - Makriyannis, Alexandros

    AU - Tius, Marcus A.

    PY - 1998/9/10

    Y1 - 1998/9/10

    N2 - The stereoelectronic requirements for interaction of the southern aliphatic hydroxyl of cannabimimetic pharmacophores with the CB1 and CB2 receptors are explored. The stereoselective syntheses of three series of classical/nonclassical hybrid cannabinoids are described. These compounds were designed to investigate the importance of the southern aliphatic hydroxyl (SAH) pharmacophore for cannabimimetic activity. Variation in the chain length of the SAH moiety in these 6β-(hydroxyalkyl)dihydrobenzopyran analogues, from 6β-hydroxymethyl to 6β(ω-hydroxyethyl) and 6β-(ω- hydroxypropyl), and the effects of replacing the hydroxyl functional, ity by hydride and iodide are reported. Our results indicate that the SAH pharmacophore has less pronounced effects than the C-3 aliphatic chain on cannabinoid activity. Furthermore, it appears that this southern molecular component is capable of interacting with two different subsites on the receptor and that the nature of this interaction is determined by the terminal substituent on the C-6β alkyl group. One of the subsites can accommodate the relatively polar SAH pharmacophore, while the second subsite interacts with more hydrophobic C-6β substituents and can accommodate large spherical pharmacophores separated by three methylene carbons from the tricyclic cannabinoid template.

    AB - The stereoelectronic requirements for interaction of the southern aliphatic hydroxyl of cannabimimetic pharmacophores with the CB1 and CB2 receptors are explored. The stereoselective syntheses of three series of classical/nonclassical hybrid cannabinoids are described. These compounds were designed to investigate the importance of the southern aliphatic hydroxyl (SAH) pharmacophore for cannabimimetic activity. Variation in the chain length of the SAH moiety in these 6β-(hydroxyalkyl)dihydrobenzopyran analogues, from 6β-hydroxymethyl to 6β(ω-hydroxyethyl) and 6β-(ω- hydroxypropyl), and the effects of replacing the hydroxyl functional, ity by hydride and iodide are reported. Our results indicate that the SAH pharmacophore has less pronounced effects than the C-3 aliphatic chain on cannabinoid activity. Furthermore, it appears that this southern molecular component is capable of interacting with two different subsites on the receptor and that the nature of this interaction is determined by the terminal substituent on the C-6β alkyl group. One of the subsites can accommodate the relatively polar SAH pharmacophore, while the second subsite interacts with more hydrophobic C-6β substituents and can accommodate large spherical pharmacophores separated by three methylene carbons from the tricyclic cannabinoid template.

    UR - http://www.scopus.com/inward/record.url?scp=0032505136&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0032505136&partnerID=8YFLogxK

    U2 - 10.1021/jm960677q

    DO - 10.1021/jm960677q

    M3 - Article

    VL - 41

    SP - 3596

    EP - 3608

    JO - Journal of Medicinal Chemistry

    JF - Journal of Medicinal Chemistry

    SN - 0022-2623

    IS - 19

    ER -